LIBX-A402

LIBX-A402 (Compound 15b) is a selective ACSL4 inhibitor with an IC50 of 0.33 μM. It notably safeguards MDA-MB-231 and LUHMES cells from ferroptosis. LIBX-A402 is applicable in research focused on cancer, ischemia-reperfusion injury, and neurodegenerative disorders such as Parkinson's disease.